A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors

References

• Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005; 62: 1204–16
   PubMed Web of Science ®Google Scholar
• Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005; 62: 1195–203
   PubMed Web of Science ®Google Scholar
• Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 1995; 22: 63–82
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 1999; 353(9149)267–72
   PubMed Web of Science ®Google Scholar
• Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57–62
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000; 55: 241–9
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ask A, Bjelkengren G, Bjork-Eriksson T, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005; 44: 836–49
   PubMed Web of Science ®Google Scholar
• Cella L, Lomax A, Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001; 49: 217–23
   PubMed Web of Science ®Google Scholar
• Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 2004; 72: 129–38
   PubMed Web of Science ®Google Scholar
• Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001; 61: 287–97
   PubMed Web of Science ®Google Scholar
• Mu X, Bjork-Eriksson T, Nill S, Oelfke U, Johansson KA, Gagliardi G, et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005; 44: 554–62
   PubMed Web of Science ®Google Scholar
• Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys 2004; 58: 1596–606
   PubMed Web of Science ®Google Scholar
• Van der Giessen PH. A simple and generally applicable method to estimate the peripheral dose in radiation teletherapy with high energy x-rays or gamma radiation. Int J Radiat Oncol Biol Phys 1996; 35: 1059–68
   PubMedGoogle Scholar
• Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, et al. Erratum: “Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36”[Med Phys 1995;22:63–82]. Med Phys 1995; 22: 1353–4
   Google Scholar
• Jordan TJ. Central axis depth dose data for use in radiotherapy Section 5: Megavoltage X-ray beams: 2–50 MV. Br J Radiol 1996; (Suppl 25): 62–109
   Google Scholar
• Epstein RJ, Kelly SA, Cook M, Bateman A, Paddick I, Kam KC, et al. Active minimisation of radiation scatter during breast radiotherapy: Management implications for young patients with good-prognosis primary neoplasms. Radiother Oncol 1996; 40: 69–74
   PubMedGoogle Scholar
• Mutic S, Esthappan J, Klein EE. Peripheral dose distributions for a linear accelerator equipped with a secondary multileaf collimator and universal wedge. J Appl Clin Med Phys 2002; 3: 302–9
   PubMedGoogle Scholar
• Mutic S, Klein EE. A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. American Association of Physicists in Medicine Task Group 36. Int J Radiat Oncol Biol Phys 1999; 44: 947–53
   PubMedGoogle Scholar
• Stern RL. Peripheral dose from a linear accelerator equipped with multileaf collimation. Med Phys 1999; 26: 559–63
   PubMed Web of Science ®Google Scholar
• Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin's disease in early pregnancy: Embryo dose measurements. Radiother Oncol 2003; 66: 333–9
   PubMed Web of Science ®Google Scholar
• Sharma DS, Animesh, Deshpande SS, Phurailatpam RD, Deshpande DD, Shrivastava SK, et al. Peripheral dose from uniform dynamic multileaf collimation fields: Implications for sliding window intensity-modulated radiotherapy. Br J Radiol 2006; 79(940)331–5
   PubMedGoogle Scholar
• Petti PL, Chuang CF, Smith V, Larson DA. Peripheral doses in CyberKnife radiosurgery. Med Phys 2006; 33: 1770–9
   PubMed Web of Science ®Google Scholar
• Jeraj R, Mackie TR, Balog J, Olivera G, Pearson D, Kapatoes J, et al. Radiation characteristics of helical tomotherapy. Med Phys 2004; 31: 396–404
   PubMed Web of Science ®Google Scholar
• Ramsey CR, Seibert R, Mahan SL, Desai D, Chase D. Out-of-field dosimetry measurements for a helical tomotherapy system. J Appl Clin Med Phys 2006; 7: 1–11
   PubMedGoogle Scholar
• Meeks SL, Paulino AC, Pennington EC, Simon JH, Skwarchuk MW, Buatti JM. In vivo determination of extra-target doses received from serial tomotherapy. Radiother Oncol 2002; 63: 217–22
   PubMedGoogle Scholar
• Mutic S, Low DA. Whole-body dose from tomotherapy delivery. Int J Radiat Oncol Biol Phys 1998; 42: 229–32
   PubMedGoogle Scholar
• Reft CS, Runkel-Muller R, Myrianthopoulos L. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT. Med Phys 2006; 33: 3734–42
   PubMedGoogle Scholar
• Roy SC, Sandison GA. Shielding for neutron scattered dose to the fetus in patients treated with 18 MV x-ray beams. Med Phys 2000; 27: 1800–3
   PubMed Web of Science ®Google Scholar
• Binns PJ, Hough JH. Secondary dose exposures during 200 MeV proton therapy. Radiat Prot Dosim 1997; 70: 441–4
   Google Scholar
• Mesoloras G, Sandison GA, Stewart RD, Farr JB, Hsi WC. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. Med Phys 2006; 33: 2479–90
   PubMed Web of Science ®Google Scholar
• Polf JC, Newhauser WD. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys Med Biol 2005; 50: 3859–73
   PubMedGoogle Scholar
• Roy SC, Sandison GA. Scattered neutron dose equivalent to a fetus from proton therapy of the mother. Radiat Phys Chem 2004; 71: 997–8
   Google Scholar
• Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 2002; 53: 244–51
   PubMed Web of Science ®Google Scholar
• Yan X, Titt U, Koehler AM, Newhauser WD. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nuclear Inst Methods Phys Res A 2002; 476: 429–34
   Google Scholar
• Agosteo S, Birattari C, Caravaggio M, Silari M, Tosi G. Secondary neutron and photon dose in proton therapy. Radiother Oncol 1998; 48: 293–305
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang B, Xu XG, Suit HD, Paganetti H. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol 2005; 50: 4337–53
   PubMed Web of Science ®Google Scholar
• Howell RM, Hertel NE, Wang Z, Hutchinson J, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 2006; 33: 360–8
   PubMed Web of Science ®Google Scholar
• Vanhavere F, Huyskens D, Struelens L. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. Radiat Prot Dosimetry 2004; 110: 607–12
   PubMed Web of Science ®Google Scholar
• Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, et al. Measurements of the equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys Med Biol 1999; 44: 1289–98
   PubMedGoogle Scholar
• Followill D, Geis P, Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997; 38: 667–72
   PubMed Web of Science ®Google Scholar
• Goddu S, Mutic S, Grigsby J, Santanam L, Low D. Whole-body dose for helical tomotherapy. Med Phys 2006; 33: 2150
   Google Scholar
• Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999; 53: 199–203
   PubMed Web of Science ®Google Scholar
• Glimelius B, Isacsson U, Blomquist E, Grusell E, Jung B, Montelius A. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol 1999; 38: 137–45
   PubMed Web of Science ®Google Scholar
• Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 1998; 128: 114–7
   PubMed Web of Science ®Google Scholar
• Boice JD, Jr, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74: 955–75
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88: 398–406
   PubMed Web of Science ®Google Scholar
• Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83–8
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006; 176: 1415–9
   PubMed Web of Science ®Google Scholar
• Aoyama H, Westerly DC, Mackie TR, Olivera GH, Bentzen SM, Patel RR, et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 2006; 64: 962–7
   PubMed Web of Science ®Google Scholar
• Johansson J. Thesis: Comparative treatment planning in radiotherapy and clinical impact of proton relative biological effectiveness. Acta Universitatis Upsaliensis, Uppsala 2006
   Google Scholar
• Johansson J, Isacsson U, Lindman H, Montelius A, Glimelius B. Node-positive left-sided breast cancer patients after breast-conserving surgery: Potential outcomes of radiotherapy modalities and techniques. Radiother Oncol 2002; 65: 89–98
   PubMed Web of Science ®Google Scholar
• Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier PA, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 1999; 51: 257–71
   PubMed Web of Science ®Google Scholar
• Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92
   PubMed Web of Science ®Google Scholar
• Mock U, Bogner J, Georg D, Auberger T, Potter R. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005; 181: 448–55
   PubMed Web of Science ®Google Scholar
• Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004; 58: 147–54
   PubMed Web of Science ®Google Scholar
• Pirzkall A, Carol M, Lohr F, Hoss A, Wannenmacher M, Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys 2000; 48: 1371–80
   PubMed Web of Science ®Google Scholar